Myopathy in a patient with systemic AA amyloidosis possibly induced by psoriasis vulgaris: An autopsy case

Hajime Tanabe1, Yoshimitsu Maki1, Shogo Urabe2

  • 1Department of Neurology, Oita Prefectural Hospital, 476 Bunyo, Oita, 870-0855, Japan.

Muscle & Nerve
|July 17, 2015
PubMed
Abstract

Insights

This autopsy case reveals amyloid A (AA) amyloidosis causing myopathy in a patient with psoriasis. AA amyloid deposition was found in muscles, a rare occurrence previously unreported in secondary amyloidosis.

Area of Science:

  • Neurology
  • Pathology
  • Rheumatology

Background:

  • Amyloid myopathy is a rare manifestation of primary systemic amyloid light-chain (AL) amyloidosis.
  • It has not been previously reported in secondary amyloid A (AA) amyloidosis.

Observation:

  • A 46-year-old man with psoriasis vulgaris presented with progressive limb weakness and hypertrophic cardiomyopathy.
  • Muscle biopsy showed mild inflammatory myopathy.
  • The patient died of cardiopulmonary arrest.

Findings:

  • Autopsy revealed amyloid plaques immunopositive for AA amyloid in the muscle.
  • These plaques were located in the perimysial, perivascular, and endomysial regions.
  • The diagnosis was systemic AA amyloidosis with muscle amyloid angiopathy, potentially linked to psoriasis vulgaris.

Implications:

  • This is an extremely rare autopsy case of myopathy in systemic AA amyloidosis.
  • The significant amyloid deposition in muscle blood vessel walls is unusual and warrants further investigation.
  • Highlights a potential, previously unreported, complication of AA amyloidosis.

Related Concept Videos

Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.5K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.2K
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining,...
13.1K
Amyloid Fibrils03:03

Amyloid Fibrils

7.0K
Cross-bridge Cycle01:26

Cross-bridge Cycle

As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
125.1K